Adrenal gland disorder
MONDO:0005495A disease involving the adrenal gland.
Also known as: adrenal gland disease, adrenal gland disease or disorder, adrenal gland diseases, adrenal gland disorder, adrenal gland disorders, disease of adrenal gland, disease or disorder of adrenal gland, disorder of adrenal gland
299 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Tighter blood pressure target may slash heart risks in hormone disorder
Disease control Not yet recruitingThis trial compares two blood pressure targets in people with primary aldosteronism, a hormonal condition that causes high blood pressure. One group aims for a systolic pressure below 120 mmHg (intensive), the other between 120 and 140 mmHg (standard). Over 6 to 10 years, researc…
Phase: NA • Sponsor: Chongqing Medical University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a drug tame excess cortisol in a common hormone disorder?
Disease control Not yet recruitingThis study tests whether the drug metyrapone can safely lower cortisol levels in people with mild autonomous cortisol secretion (MACS), a condition where the adrenal glands produce too much cortisol. Participants will receive either metyrapone or a placebo for a short period, and…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study could change how Men's UTIs are treated
Disease control Not yet recruitingThis study tests whether a common antibiotic for women's UTIs, fosfomycin-trometamol, works well for men with urinary tract infections. Current treatments can have serious side effects and increase antibiotic resistance. The trial will enroll 138 men in primary care and monitor f…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug SAL0140 aims to tame Hormone-Driven high blood pressure
Disease control Not yet recruitingThis phase 2 trial tests a new drug called SAL0140 in 50 adults with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. Participants will receive either SAL0140 or a placebo for 12 weeks to see if it safely lowers b…
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New cortisol timing therapy may improve life for adults with rare hormone disorder
Disease control Not yet recruitingThis study follows 100 adults with congenital adrenal hyperplasia (CAH) who switch from standard steroids to a timed-release hydrocortisone (Efmody). The goal is to see if better mimicking the body's natural cortisol rhythm improves hormone levels, metabolic health, and quality o…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New weekly shot could help adults with growth hormone deficiency
Disease control Not yet recruitingThis Phase 2a trial tests a new long-acting growth hormone injection called inpegsomatropin in 36 adults with growth hormone deficiency. Participants receive different doses or a placebo once a week to check safety and how well the drug works. The goal is to see if this weekly sh…
Phase: PHASE2 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Steroid showdown: which strategy prevents adrenal crisis after surgery?
Disease control Not yet recruitingThis study compares two ways of managing steroid replacement after adrenalectomy (removal of an adrenal gland). One approach gives steroids to everyone right after surgery, while the other withholds them if a morning blood test shows normal cortisol levels. The goal is to see whi…
Phase: NA • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could a month of hydrocortisone protect kidneys after adrenal surgery?
Disease control Not yet recruitingThis study looks at whether giving hydrocortisone for one month after adrenal gland removal can slow kidney function decline in patients with primary aldosteronism and chronic kidney disease. About 90 adults will be randomly assigned to receive either hydrocortisone or standard c…
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Italian study examines targeted radiation for rare gland tumors
Disease control Not yet recruitingThis study looks back at how well a type of targeted radiation therapy (PRRT) works for people with advanced pheochromocytoma and paraganglioma, rare tumors of the adrenal glands. Researchers will analyze data from about 210 patients treated in Italy over 24 years. The goal is to…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill could tame Hormone-Driven high blood pressure
Disease control Not yet recruitingThis study tests an experimental drug called QLS1410 for people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. The trial will compare the drug to a placebo in 60 adults to see if it safely lowers blood pres…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for toddlers with rare hormone disorder?
Disease control Not yet recruitingThis study tests a drug called crinecerfont in 20 children aged 3 months to 4 years with classic congenital adrenal hyperplasia (CAH). The goal is to see if the drug is safe and tolerable. Participants must already be on stable hydrocortisone treatment. The study is not yet recru…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for Cushing's patients with high blood pressure
Disease control Not yet recruitingThis study tests a drug called osilodrostat in 63 adults with Cushing's syndrome and high blood pressure. The goal is to see if it can safely lower blood pressure by reducing cortisol levels. Participants will take the drug or a placebo for 30 weeks, with doses adjusted based on …
Phase: PHASE4 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Steroid tapering showdown: which method wins for RA patients?
Disease control Not yet recruitingThis study compares two strategies for slowly reducing prednisolone (a steroid) in people with stable rheumatoid arthritis. One method splits a 5 mg tablet into halves, the other reduces by 1 mg at a time. Over six months, 206 participants will be followed to see which approach k…
Phase: PHASE4 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Radiation after surgery may keep rare adrenal cancer at bay
Disease control Not yet recruitingThis study looks at whether giving radiation therapy after surgery can help prevent high-risk adrenocortical carcinoma from coming back. Fifty-eight patients who had their tumor completely removed will be randomly assigned to either receive radiation or just be monitored. The mai…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
New imaging agent could improve detection of rare cancers
Diagnosis Not yet recruitingThis study will compare a new radioactive tracer, 18F-AmBF3TATE, to the standard tracer 68Ga-DOTATATE for PET scans in people with neuroendocrine tumors. The goal is to see if the new tracer is as good or better at finding tumors. About 51 participants will receive both tracers a…
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New scan could spot invisible brain tumors
Diagnosis Not yet recruitingThis study tests whether a special PET scan (18FET) can find small pituitary tumors that standard MRI scans miss. About 30 adults with suspected hormone-secreting pituitary tumors will receive the scan. If it works, it could help doctors decide on surgery or radiation without nee…
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Blood test may end need for risky vein sampling in adrenal hypertension
Diagnosis Not yet recruitingThis study tests whether measuring certain hormones in a blood sample can accurately identify which patients with primary aldosteronism (a common cause of high blood pressure) have a curable adrenal tumor. Currently, diagnosis often requires an invasive procedure called adrenal v…
Phase: NA • Sponsor: Changi General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Music therapy from home: a new hope for autoimmune and depression?
Symptom relief Not yet recruitingThis study explores whether 8 weekly telehealth music therapy sessions can improve quality of life and reduce depression and anxiety in adults with autoimmune endocrine diseases (like Type 1 diabetes or Hashimoto's) who also have depression. Ten participants will meet with a boar…
Phase: NA • Sponsor: Appalachian State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Could pomegranate supplements help heal the gut in Alcohol-Related liver disease?
Knowledge-focused Not yet recruitingThis study investigates how pomegranate dietary supplements influence gut bacteria and inflammation in people with alcohol use disorder and alcohol-related liver disease. Researchers will measure levels of beneficial gut metabolites called urolithins and inflammatory markers in b…
Sponsor: University of Louisville • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New program aims to smooth healthcare transition for teens with rare hormone disorder
Knowledge-focused Not yet recruitingThis study tests a structured program to help 40 adolescents and young adults with congenital adrenal hyperplasia (CAH) move from pediatric to adult healthcare. Participants will learn about their condition, emergency preparedness, and self-management. The goal is to see if the p…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tiny trial to see if a dye helps adrenal surgery
Knowledge-focused Not yet recruitingThis study will look at 12 people having surgery to remove an adrenal gland (adrenalectomy) using robotic or laparoscopic methods. Some surgeries will use a green dye called Indocyanine Green (ICG) to help the surgeon see better, while others will not. The main goal is to track c…
Sponsor: University of Roma La Sapienza • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
300 belgian kids to help unlock growth Hormone's metabolic secrets
Knowledge-focused Not yet recruitingThis study will follow 300 Belgian children with growth hormone deficiency for three years to see how their bodies respond to daily or weekly growth hormone shots. Researchers will measure growth, weight, blood sugar, fats, and other health markers. The goal is to understand whic…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Virtual doppelgänger may help pick right patients for kidney nerve treatment
Knowledge-focused Not yet recruitingThis pilot study will test whether a personalized computer model, called a 'digital twin,' can predict which patients with high blood pressure will respond to a procedure called renal denervation. The study will enroll 60 people, including those with resistant hypertension, untre…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Fasting during ramadan: new study checks safety for adrenal patients
Knowledge-focused Not yet recruitingThis study looks at whether fasting during Ramadan is safe for people with primary adrenal insufficiency, a condition where the adrenal glands don't make enough hormones. Researchers will monitor 35 patients for low blood sugar and dehydration during two weeks of fasting and two …
Phase: NA • Sponsor: Hopital La Rabta • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Heart complications after adrenal surgery under the microscope
Knowledge-focused Not yet recruitingThis observational study will follow 522 adults across Europe who are having surgery to remove an adrenal gland tumor. The goal is to track heart-related complications within 30 days after surgery and understand how different hospitals prepare patients beforehand. By collecting r…
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC